Simone Schoenwaelder is a Conjoint Associate Professor in the School of Medical Sciences within the Faculty of Medicine and Health at the University of Sydney and an Associate Professor at the Heart Research Institute, Charles Perkins Centre. She earned her Bachelor of Science with Honours from Monash University in 1992 and her PhD from the same institution at the Australian Centre for Blood Diseases in 1996. Following her doctoral studies, she pursued postdoctoral research and advanced to positions at Monash University's Department of Clinical Haematology and Australian Centre for Blood Diseases, serving from April 2004 to January 2015. In 2015, she relocated to Sydney, joining the Heart Research Institute and the University of Sydney, where she continues as a key researcher and supervisor for honours and summer scholarship projects in physiology and medical sciences.

Schoenwaelder's academic interests center on platelet biology, including activation, aggregation, signal transduction, hemostasis, thrombosis, apoptosis, and cell signaling, with particular emphasis on atherothrombosis and novel anticoagulant development for stroke prevention and treatment. She has authored over 110 publications, accumulating more than 7,460 citations. Key contributions include 'Intrinsic apoptosis circumvents the functional decline of circulating platelets, but does not cause the storage lesion' (2018), 'Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets' (2018), 'Neutrophil macroaggregates promote widespread pulmonary thrombosis after gut ischemia' (2017, JCI Insight), 'Endogenous fibrinolysis facilitates clot retraction in vivo' (2017), and '14-3-3ζ regulates the mitochondrial respiratory reserve linked to platelet phosphatidylserine exposure and procoagulant function' (2016). Her research has garnered major awards and funding, such as the NHMRC Project Grant of $750,000 in 2020 for developing safer anticoagulants for stroke treatment, the Brain Foundation Research Gift in 2019, and NSW Cardiovascular Research Capacity Building Grants. Associated with Shaun P. Jackson's Lab, her work influences antithrombotic therapies, including tick-derived compounds advancing to clinical trials. She has delivered public lectures, including at the University of Sydney Women's College, and currently heads Biology at Thrombio Pty Ltd.

Professional Email: simone.schoenwaelder@sydney.edu.au